M. J. GILL, M.B., M.SC., F.R.C.P.(C); J. ARLETTE, M.D., F.R.C.P.(C); K. BUCHAN, M.B., Ch.B.; D. L. TYRRELL, M.D., Ph.D., F.R.C.P.(C)
This content is PDF only. Please click on the PDF icon to access.
To the editor: Herpesvirus infection of the hand was first described in 1909 (1). Since then, its recurrent nature and a high incidence in various populations, such as health care professionals and patients with genital herpes, have been well described (2, 3). No therapy has been found to be of great value, although in one patient, chronic therapy with oral acyclovir appeared to suppress recurrences of herpetic whitlow (4).
In recurrent genital herpes, some evidence suggests that oral acyclovir therapy, initiated during the prodromal phase, may either abort or shorten the duration of the recurrence (5). In herpetic whitlow, the
GILL MJ, ARLETTE J, BUCHAN K, et al. Therapy for Recurrent Herpetic Whitlow. Ann Intern Med. 1986;105:631. doi: 10.7326/0003-4819-105-4-631_1
Download citation file:
Published: Ann Intern Med. 1986;105(4):631.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use